203 related articles for article (PubMed ID: 1626178)
1. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
Schutter EM; Visser JJ; van Kamp GJ; Mensdorff-Pouilly S; van Dijk W; Hilgers J; Kenemans P
Tumour Biol; 1992; 13(3):121-32. PubMed ID: 1626178
[TBL] [Abstract][Full Text] [Related]
2. [Relation between lipid-bound sialic acid in blood serum and plasma andin human tumors].
Polívková J; Vosmiková K; Pospísil J; Poucková P
Bratisl Lek Listy; 1992 May; 93(5):222-4. PubMed ID: 1393642
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipid-bound sialic acid alterations in neoplastic diseases.
Dwivedi C; Dixit M; Hardy RE
Experientia; 1990 Jan; 46(1):91-4. PubMed ID: 2298288
[TBL] [Abstract][Full Text] [Related]
4. Lipid bound sialic acid in cancer patients.
Salvagno L; Ferrazzi E; Sileni VC; Maggi S; Tredese F; Bedendo C; Russo MP; Fiorentino MV; Ceriotti G
Tumori; 1985 Apr; 71(2):127-33. PubMed ID: 4002346
[TBL] [Abstract][Full Text] [Related]
5. Individual and combined usefulness of lipid associated sialic acid, mucoid proteins and hexoses as tumor markers in breast carcinoma.
Patel PS; Baxi BR; Adhvaryu SG; Balar DB
Cancer Lett; 1990 Jun; 51(3):203-8. PubMed ID: 2161706
[TBL] [Abstract][Full Text] [Related]
6. Comparison of serum CA-125 and lipid-associated sialic acid (LASA-P) in monitoring patients with invasive ovarian adenocarcinoma.
Patsner B; Mann WJ; Vissicchio M; Loesch M
Gynecol Oncol; 1988 May; 30(1):98-103. PubMed ID: 2452774
[TBL] [Abstract][Full Text] [Related]
7. Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.
Musset M; Mathé G; Reizenstein P
Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):17-20. PubMed ID: 2663215
[TBL] [Abstract][Full Text] [Related]
8. Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck.
Dreyfuss AI; Clark JR; Andersen JW
Cancer; 1992 Nov; 70(10):2499-503. PubMed ID: 1423179
[TBL] [Abstract][Full Text] [Related]
9. Lipid-bound sialic acid as a tumor marker.
Dnistrian AM; Schwartz MK
Ann Clin Lab Sci; 1983; 13(2):137-42. PubMed ID: 6859805
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of lipid-bound sialic acid (LSA) as a tumor marker.
López Sáez JJ; Senra-Varela A
Int J Biol Markers; 1995; 10(3):174-9. PubMed ID: 8551061
[TBL] [Abstract][Full Text] [Related]
11. Plasma lipid-bound sialic acid and carcinoembryonic antigen in cancer patients.
Dnistrian AM; Schwartz MK
Clin Chem; 1981 Oct; 27(10):1737-9. PubMed ID: 7285326
[TBL] [Abstract][Full Text] [Related]
12. The significance of serum lipid-bound sialic acid in bladder tumours.
Oztokatli A; Ozkardeş H; Ovül E; Erol D
Int Urol Nephrol; 1992; 24(2):125-9. PubMed ID: 1624255
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of putative tumor markers for malignant melanoma.
Reintgen DS; Cruse CW; Wells KE; Saba HI; Fabri PJ
Ann Plast Surg; 1992 Jan; 28(1):55-9. PubMed ID: 1642407
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer and family history: levels of lipid-associated sialic acid in plasma and absent family history of breast cancer in women who have breast tumors.
Brower ST; Tartter P; Weiss S; Luderer AA; Lehrer S
Mt Sinai J Med; 1995 Nov; 62(6):419-21. PubMed ID: 8692154
[TBL] [Abstract][Full Text] [Related]
15. [Serum lipid-associated sialic acid (LSA) in diagnosing and monitoring ovarian cancer].
Yue K; Bian M; Zhu D; Liu W; Siu S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):128-32. PubMed ID: 7656393
[TBL] [Abstract][Full Text] [Related]
16. Improved procedure for determination of serum lipid-associated sialic acid: application for early diagnosis of colorectal cancer.
Tautu C; Verazin G; Prorok JJ; Alhadeff JA
J Natl Cancer Inst; 1988 Oct; 80(16):1333-7. PubMed ID: 3172258
[TBL] [Abstract][Full Text] [Related]
17. Total and lipid-bound serum sialic acid as markers for carcinoma of the uterine cervix.
Vivas I; Spagnuolo L; Palacios P
Gynecol Oncol; 1992 Aug; 46(2):157-62. PubMed ID: 1500016
[TBL] [Abstract][Full Text] [Related]
18. Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement.
Plucinsky MC; Riley WM; Prorok JJ; Alhadeff JA
Cancer; 1986 Dec; 58(12):2680-5. PubMed ID: 3779617
[TBL] [Abstract][Full Text] [Related]
19. Increase of serum lipid-associated sialic acid concentration in dogs with neoplasms.
Poli A; Arispici M; Camillo F; Corazza M
Am J Vet Res; 1986 Mar; 47(3):607-9. PubMed ID: 3754401
[TBL] [Abstract][Full Text] [Related]
20. Determination of serum total lipid and free N-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of free N-acetylneuraminic acid as tumour marker.
Laganà A; Pardo-Martínez B; Marino A; Fago G; Bizzarri M
Clin Chim Acta; 1995 Dec; 243(2):165-79. PubMed ID: 8747492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
